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Abstract. Computer modeling has become the commonly used method to explain biological 
activity of substances [1]. Despite the technical attractiveness of this approach, there are serious 
difficulties in creating a theoretical model that would correspond to the experimental data [2]. The purpose 
of this mini-review is to systematize scientific efforts to predict the binding site of benzimidazol-2-yl 
carbamate derivatives with β-tubulin. Interest in the generalization of these studies is due to the fact that 
while the crystal structure of the complex tubulin with methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-
2-yl] carbamate 1 was published only in 2015 (PDB id 5CA1, Figure 1), some details of the interaction 
of benzimidazol-2-yl carbamates with β-tubulin could be predicted before it. This mini-review 
summarizes the results of such works. 
 
 
Figure 1. Nocodazole complex with tubulin (PDB id 5CA1). 
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